Zila’s Oral Cancer Screening Product, ViziLite Plus, Featured at BDTA Dental Showcase in London

PHOENIX--(BUSINESS WIRE)--Zila, Inc. (NASDAQ:ZILAD) today announced that ViziLite® Plus with TBlue®, its flagship oral cancer screening product, will be prominently featured at the British Dental Trade Association (BDTA) Dental Showcase in London on October 2-4, 2008. The BDTA meeting will be held at ExCeL London, the international exhibition and conference centre. The BDTA is attended by more than 10,000 dental professionals and has over 300 companies exhibiting.

MORE ON THIS TOPIC